Integra LifeSciences Reports Fourth Quarter 2013 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- S&P 500, Nasdaq rise in choppy trading as tech steadies, Micron results in focus
- Brent hits lowest since before start of Iran war on expectations of smoother oil flows via Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Integra Lifesciences Holdings (IART) Misses Q4 EPS by 3c
February 25, 2014 6:36 AM ESTIntegra Lifesciences Holdings (NASDAQ: IART) reported Q4 EPS of $0.78, $0.03 worse than the analyst estimate of $0.81. Revenue for the quarter came in at $220.8 million versus the consensus estimate of $223.37 million.
Integra Lifesciences Holdings sees FY2014 revenue of $920-940 million, versus the consensus of $932.3 million.... More
